Humacyte, Inc. Effective Tax Rate
Humacyte, Inc. (HUMA) reported Effective Tax Rate of 0.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-12
- Humacyte, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 0.00%.
- Humacyte, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 0.00%.
- Humacyte, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 0.00%.
- Humacyte, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 0.00%.
- Humacyte, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- Humacyte, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
- Humacyte, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- Humacyte, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-12 | 0.00% 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-27 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-12 | 0.00% 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-12 | 0.00% 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-27 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-12 | 0.00% 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-11 | 0.00% 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-08 | 0.00% 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-13 | 0.00% 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-28 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-09 | 0.00% 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-14 | 0.00% 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-24 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-10 | 0.00% 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-12 | 0.00% 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-29 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-15 | 0.00% 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |